4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3,4:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[34:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)phenyl)butan-1-one for treating conditions of the central nervous system and cardiac disorders | Patent Number 11753419
US 11753419 B2Filled DateDec 10, 2020
Priority DateDec 11, 2019
Publication DateJan 26, 2023
Expiration DateDec 10, 2039
Inventor/ApplicantsRobert E Davis
Robert E DAVIS
Kimberly Vanover
Peng LI
Peng Li
Robert E DAVIS
Kimberly Vanover
Peng LI
Peng Li
ExaminesWILLIS, DOUGLAS M
Art Unit1624
Technology Center1600
Law Firm
You must be logged in to view
LoginAttorneys
Module Locked
International
2
A61K
C07D
National
0
Field of Search
0
Patent Claims data is locked.
Login To View
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.